Novonesis biosolutions for human health – advancing well-being through science-driven innovation
Home
Evolva capitalizes on...

Evolva capitalizes on megatrends as revenues jump 31%, reaching US$10.6M

11 Mar 2022
-
Aa
+
NutritionInsight Global EMEA
trans